2004
DOI: 10.1128/jvi.78.3.1289-1300.2004
|View full text |Cite
|
Sign up to set email alerts
|

Specific Inhibition of Human Cytomegalovirus Glycoprotein B-Mediated Fusion by a Novel Thiourea Small Molecule

Abstract: A novel small molecule inhibitor of human cytomegalovirus (HCMV) was identified as the result of screening a chemical library by using a whole-virus infected-cell assay. Synthetic chemistry efforts yielded the analog designated CFI02, a compound whose potency had been increased about 100-fold over an initial inhibitor. The inhibitory concentration of CFI02 in various assays is in the low nanomolar range. CFI02 is a selective and potent inhibitor of HCMV; it has no activity against other CMVs, alphaherpesviruse… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
32
0

Year Published

2004
2004
2013
2013

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 36 publications
(34 citation statements)
references
References 58 publications
2
32
0
Order By: Relevance
“…These proteins apparently pilot gB transition through a WY1768-sensitive, PrK-resistant intermediate, and so WY1768 would irreversibly trap VR1814 TM in a PrK-resistant form. This explanation is fully consistent with previous findings that thiourea inhibitors require virus attachment to be effective and that their viral target is gB, because the point mutations that confer WY1768 resistance map within TM pretransmembrane and transmembrane alpha-helical stretches (33).…”
Section: Vol 81 2007 Hcmv Ul131-128 Products and Gb-gh Interaction supporting
confidence: 80%
See 1 more Smart Citation
“…These proteins apparently pilot gB transition through a WY1768-sensitive, PrK-resistant intermediate, and so WY1768 would irreversibly trap VR1814 TM in a PrK-resistant form. This explanation is fully consistent with previous findings that thiourea inhibitors require virus attachment to be effective and that their viral target is gB, because the point mutations that confer WY1768 resistance map within TM pretransmembrane and transmembrane alpha-helical stretches (33).…”
Section: Vol 81 2007 Hcmv Ul131-128 Products and Gb-gh Interaction supporting
confidence: 80%
“…The bis-(aryl)thiourea inhibitor WY1768 is a potent inhibitor of HCMV fusion in FBs (3,33) and retains its activity on VR1814 strain infections of ECs (50% infective dose in ECs, 1.96 Ϯ 0.06 nM [mean Ϯ standard deviation {SD}; n ϭ 4] [data not shown]), suggesting that the affected mechanism is essential for HCMV entry in both cell types. When the lipid mixing assay was performed in the presence of 2 M WY1768, the VR1814 virus failed to transfer R18 fluorescence to either ECs or HELFs.…”
Section: Resultsmentioning
confidence: 99%
“…It was shown previously that inhibition of HCMV virion fusion by CFI02 could be reversed by the treatment of virion-adsorbed cells with a fusion-inducing polymer, polyethylene glycol (PEG) (7). HFF cells were infected with HCMV in the absence or presence of a fusion inhibitor, CFI02, and then treated with PEG (Fig.…”
mentioning
confidence: 99%
“…To further determine if the inhibition of ISG induction by CFI02 was secondary to an inhibition of virion-cell fusion, a protocol adapted to study the effect of CFI02 on HCMV infectivity was utilized (7). It was shown previously that inhibition of HCMV virion fusion by CFI02 could be reversed by the treatment of virion-adsorbed cells with a fusion-inducing polymer, polyethylene glycol (PEG) (7).…”
mentioning
confidence: 99%
See 1 more Smart Citation